MYO1A Gene Deafness autosomal dominant type 48 Genetic Test
Welcome to DNA Labs UAE, where we offer the MYO1A Gene Deafness autosomal dominant type 48 Genetic Test. This test is designed to identify mutations in the MYO1A gene that are associated with deafness type 48 (DFNA48), a form of autosomal dominant deafness.
Test Components and Price
The MYO1A Gene Deafness autosomal dominant type 48 Genetic Test is priced at 4400.0 AED. The test requires a sample of either blood, extracted DNA, or one drop of blood on an FTA Card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology, which allows for the sequencing of the entire coding region of the MYO1A gene.
Test Type and Doctor
The MYO1A Gene Deafness autosomal dominant type 48 Genetic Test falls under the category of Ear Nose Throat Disorders. It is recommended to consult with an ENT Doctor for this test.
Test Department and Pre Test Information
The MYO1A Gene Deafness autosomal dominant type 48 Genetic Test is conducted by our Genetics department. It is important to provide the clinical history of the patient who is going for the test, especially if they are affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session may be required to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA5.
Test Details and Importance
The MYO1A gene is associated with autosomal dominant deafness, specifically known as deafness type 48 (DFNA48). Autosomal dominant means that only one copy of the mutated gene is needed to cause the condition. By performing an NGS genetic test on the MYO1A gene, individuals can determine if they carry a mutation associated with DFNA48. This information is crucial for diagnosis, genetic counseling, and potentially for guiding treatment options or management strategies.
Test Name | MYO1A Gene Deafness autosomal dominant type 48 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA5 |
Test Details |
The MYO1A gene is associated with a form of autosomal dominant deafness, specifically known as deafness type 48 (DFNA48). Autosomal dominant means that only one copy of the mutated gene is needed to cause the condition. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. It allows for the sequencing of the entire coding region of the MYO1A gene to identify any mutations or variants that may be present. By performing an NGS genetic test on the MYO1A gene, individuals can determine if they carry a mutation that is associated with DFNA48. This information can be useful for diagnosis, genetic counseling, and potentially for guiding treatment options or management strategies. |